Robust dual-field optimization of scanned ion beams against range and
  setup uncertainties by Inaniwa, Taku et al.
Robust dual-field optimization of scanned ion beams against range and setup uncertainties
Taku Inaniwa,a) Nobuyuki Kanematsu, Takuji Furukawa and Koji Noda
Medical Physics Research Group, Research Center for Charged Particle Therapy, National Institute
of Radiological Sciences, 4-9-1 Anagawa, Inage-ku, Chiba 263-8555, Japan
Email: taku@nirs.go.jp
Tel: +81-43-206-3170
Fax: +81-43-251-1840
Short title: Robust dual-field optimization against range and setup uncertainties
Classification numbers: 87.55.de, 87.55.dk, 02.60.Cb
Confidential: not for distribution. Submitted to IOP Publishing for peer review  11 August 2010
Abstract
A ‘dual-field’ strategy is often used for tumors with highly complex shapes and/or with large
volumes exceeding available field-size in both passive and scanning irradiations with ion beams.
Range and setup uncertainties can cause hot and cold doses at the field junction within the target.
Such uncertainties will also cause cold doses in the peripheral region of the target. We have
developed an algorithm to reduce the sensitivity of the dual-field plan to these uncertainties in
scanning irradiations. This algorithm is composed of the following two steps: 1) generating the
expanded target volume, and 2) solving the inverse problem where the terms suppressing the dose
gradient of individual fields are added into the objective function. The validity of this algorithm is
demonstrated through the simulation studies for three extreme cases of two fields with unidirectional,
opposing and orthogonal geometries. With the proposed algorithm, we can obtain a more robust
plan to minimize the effects of range and setup uncertainties than the conventional plan. Compared
to that for the conventional plan, the optimization time for the robust plan increased by a factor of
approximately three.
1. Introduction
In the past decade, there has been growing interest in cancer therapy using heavy charged particles
such as protons or heavier ions like carbon. This can be attributed to the good physical selectivity
of beams composed of these particles, resulting in an inverted dose profile with a sharp longitudinal
dose fall-off at the end of the particle range and a small lateral scattering. In addition, in the case of
carbon, the increased biological effectiveness around the Bragg peak enhances its usefulness for
radiotherapy. With these advantageous characteristics, charged particle therapy offers a high
degree of dose conformity to a tumor while preventing undesired exposures of the surrounding
normal tissues. For tumors with complex shapes like L-shaped targets in the head and neck, a
‘dual-field’ strategy is often used to avoid the critical structures located close to the tumor (Bussiere
and Adams 2003). In this strategy, two fields are combined such that the first field covers only a
part of the target, avoiding a nearby critical structure, and the second field covers the remaining
portion of the target. The ‘dual-field’ strategy is also used for large volumes exceeding the
available field-size, which is limited by the cross-sectional sizes of the beam shaping/controlling
devices on the beam line, while that in the beam direction is limited by the maximum beam energy.
In this case also, the first field is designed to partially cover the target, and the second field is used to
cover the portion of the target that is not covered by the first field. However, the ‘dual-field’
strategy is sensitive to range and setup uncertainties in both passive (Paganetti et al 2008) and pencil
beam scanning methods, i.e., intensity modulated proton/ion therapy (IMPT/IMIT) (Weber et al
2005, Rutz et al 2008, Albertini et al 2008, Lomax 2008). Range and setup errors cause hot and
cold doses within the target and cold doses in the peripheral region of the target volume. To reduce
these undesired effects, several technical approaches have been applied in passive irradiation
methods (Hug et al 2000, Li et al 2007). In IMPT/IMIT with pencil beam scanning, there usually
exist many different solutions to the inverse problem that will realize dosimetrically equivalent plans
(Lomax et al 2004). This redundancy of solutions can be used to reduce the sensitivity of treatment
plans if these uncertainties are accounted for in the optimization. Recently, several such
approaches were proposed in IMPT (Unkelbach et al 2007, Pflugfelder et al 2008, Unkelbach et al
2009), and these methods greatly reduced the sensitivity to these uncertainties of the resulting
treatment plans. However, in these approaches many possible scenarios must be considered, and
for all these scenarios the resultant dose distributions must be calculated in each iterative
optimization process, leading to computation time as long as several hours (Unkelbach et al 2009).
In this paper, we propose a simple and fast algorithm for reducing the sensitivity of the dual-field
plan to these uncertainties. In our algorithm, only a nominal scenario is considered in each iterative
optimization process by adding the terms for the sensitivity to the uncertainties into the objective
function to lead to a robust solution directly. The proposed algorithm is fully integrated into the
research version of treatment planning software developed for carbon-ion scanning (Inaniwa et al
2008). The validity of the proposed algorithm is demonstrated through the simulation studies for
three extreme cases of two fields with unidirectional, opposing and orthogonal geometries.
In IMPT/IMIT, the non-uniform dose distributions are delivered from several directions, and the
desired target coverage and the sparing of organs at risk (OARs) are obtained after superposing the
dose contributions from all fields. For simplicity, in this paper, we do not consider the OARs,
treating only target coverage in multi-field irradiations with scanned ion beams. Hence, we refer to
the proposed algorithm as ‘a robust approach for dual-field optimizations’ rather than ‘a robust
approach for IMPT/IMIT’. Furthermore, for simplicity, only the physical dose distribution is
considered in this paper.
2. Preliminary Calculations
2.1 Conventional optimization
A pencil beam algorithm is used for dose calculation. In the inverse planning, the dose-based
objective function, ( )wf , is minimized by an iterative process to determine the best particle
numbers (beam weight: w ) for each pencil beam. Here, w is the matrix notation of the beam
weights for all pencil beams. The objective function is defined as
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where fieldN is the number of incident fields, and ( )lliD w, is the dose delivered to a position i
from an incident field l with the beam weight lw . The total beam weight w has the following
relationship to the matrix lw for each incident field l:

=
=
fieldN
l
l
1
ww . (2) 
max
PD ,
min
PD ,
o
PQ , uPQ are the maximum and minimum doses applied to the target T and the
penalty coefficients for over- and under-dosage specified for the target, respectively. [ ]rH′ is
described as [ ] [ ]rrr HH =′ with the heaviside step function, [ ]rH , defined so as to take the
value of 1 only if r is greater than zero; otherwise, it takes the value of 0. In this paper, the Bragg
peak position of the pencil beam is referred to as ‘spot’. 
 
2.2 Pencil beam model
The details of the beam model used in this study were described in Inaniwa et al (2008).
Therefore, the explanation of the model is kept to a minimum here. The x and y coordinates denote
the lateral and orthogonal directions, respectively, and the z coordinate denotes the direction parallel
to the beam axis. The dose distribution delivered by the j-th pencil beam, ( )zyxd j ,, , is split into
three components, two components in transverse directions, ( )zxd jx ,: and ( )zyd jy ,: , and one,
( )zd jz: , parallel to the beam direction, and represented as follows:
( ) ( ) ( ) ( )zdzydzxdzyxd jzjyjxj ::: ,,,, = . (3) 
Here, ( )zxd jx ,: and ( )zyd jy ,: are the normalized Gaussian functions with standard deviations
( )zjx:σ and ( )zjy:σ representing the beam spread at a depth z described by
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respectively. On the other hand, ( )zd jz: is the planner-integrated dose at a depth of z .
3. Robust Optimization Algorithm
3.1 Step1: Expansion of the target
As a first step of the robust optimization method, the target volume is expanded to account for the
cold doses in the peripheral region of the target volume due to the range and setup errors. The
magnitude of the error is non-isotropic and field specific. Hence, we expand the target volume to a
volume that encompasses the target plus margins against non-isotropic errors for each incident field
direction. The expanded target volume is referred to as the ‘field-specific target volume (FTV)’ in
this paper. These errors can be split into a component parallel and a component perpendicular to
the beam axis. The range uncertainties are the component parallel to the beam axis. There are
multiple sources of range uncertainties, e.g., CT artifacts, weight gain or weight loss of a patient and
conversion from Hounsfield units (HU) to stopping powers. In this study, we assume that the range
uncertainties are proportional to the water equivalent depth, and they amount to ±5.0% as an extreme
case. On the other hand, the setup errors comprise components both parallel and perpendicular to
the beam axis. Shifts parallel to the beam axis cause an increase/decrease of the air gap in front of
the patient, but this alters the resulting dose distribution only minimally. Thus, it is sufficient to
consider only shifts perpendicular to each treatment beam to account for setup uncertainty
(Pflugfelder et al 2008). We assumed setup uncertainties of ±5 mm in the x- and y-directions, as
assumed in Lomax (2008). Spots are placed within the FTV in each incident field. On the other
hand, in dose optimizations, a volume including the FTVs in all incident fields is considered as a
dosimetric target volume (DTV).
3.2 Step2: Inverse Planning
3.2.1 Objective function
The authors of previous studies pointed out that steep longitudinal dose gradients make treatment
plans sensitive to range errors, and steep lateral dose gradients make plans sensitive to setup errors
(Pflugfelder et al 2008, Unkelbach et al 2009,Lomax 2008). Accordingly, as a robust optimization,
we directly add the terms suppressing the in-field dose gradient within the target volume to the
objective function (1), as follows:
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where xQ , yQ , zQ are the penalty coefficients for dose gradients in the two scanning directions
and beam direction, respectively. ( )lliD w, can be described by the superposition of the dose of
individual Bragg peaks, ( )zyxd j ,, , according to their weights, jw , as follows:
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where lN is the number of spots in the field l.
By using equation (7), the objective function (6) can be transformed as follows;
( )

   
  
  
   
∈
= == == =
= == =
∈ = ===
∈ = == =






































∂
∂
+





















∂
∂
+





















∂
∂
+


	












−′+


	






−





′
=






























∂
∂
+













∂
∂
+













∂
∂
+










	












−′+


	






−





′=
T
2
1 1
2
1 1
2
1 1
2
1 1
min
P
u
P
2
max
P
1 1
o
P
T 1
2
1
2
1
2
1
T
2
1 1
min
P
u
P
2
max
P
1 1
o
P
HH
HH
i N
l
N
j
j
ij
z
N
l
N
j
j
ij
y
N
l
N
j
j
ij
x
N
l
N
j
jij
N
l
N
j
jij
i
N
l
N
j
jijz
N
j
jijy
N
j
jijx
i
N
l
N
j
jij
N
l
N
j
jij
field lfield lfield l
field lfield l
field lll
field lfield l
w
z
dQw
y
dQw
x
dQ
wdDQDwdQ
wd
z
Qwd
y
Qwd
x
Q
wdDQDwdQf w
.
(8) 
The additional dose gradient suppressing terms can be derived by the convolution of the gradients
( )xdij ∂∂ , ( )ydij ∂∂ and ( )zdij ∂∂ with respect to its weight, jw , as  
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the original terms.
To solve the inverse problem using the quasi-Newton method, the objective function’s first
derivative, ( )wf∇ , has to be calculated. The j-th component of ( )wf∇ is derived as
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The quantities originating from the additional terms can be derived with the same functional form as
that from the original terms.
3.2.2 Gradients of ijd
As described in equations (8) and (9), the gradients of ijd in the x-, y- and z-directions,
( )xdij ∂∂ , ( )ydij ∂∂ and ( )zdij ∂∂ , respectively, have to be calculated for derivations of ( )wf
and ( )wf∇ . In this subsection, we derive the quantities ( )xdij ∂∂ , ( )ydij ∂∂ and ( )zdij ∂∂ .
First, we derive ( )xdij ∂∂ as follows:
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With the same transformations, we can derive ( )ydij ∂∂ as follows:
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are the derivative of the
normalized Gaussian functions with respect to the x- and y-directions, respectively.
On the other hand, the gradient of ijd in the beam-direction, ( )zdij ∂∂ , can be derived as
follows:
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3.2.3 Implementation
In equations (8) and (9), the convolutions  
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respectively. To shorten the time required for the dose optimization, preceding the dose
optimization, we prepare the filter tables of dose gradients,
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As examples, the normalized Gaussian functions with standard deviations of 3.0, 4.0 and 5.0 mm are
shown in figure 1 along with the corresponding functions of their derivatives. These filter tables
are referenced in the dose optimizations with the indices of xσ and yσ determined for a given
pencil beam j at a given depth z .
Similarly, preceding the dose optimization, the values of ( ) zzijx ∂∂ :σ , ( ) zzijy ∂∂ :σ and
z
ijzd
∂
∂ : for each pencil beam j in equation (12) are calculated in addition to the widths ( )ijx z:σ
and ( )ijy z:σ and the dose ( )ijz zd : . The derivatives of ( )zjx:σ and ( )zjy:σ with respect to z,
( ) zzjx ∂∂ :σ and ( ) zzjy ∂∂ :σ , can easily be obtained as
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As examples, the lateral beam widths ( )zjx:σ and ( )zjy:σ of a 290-MeV/u carbon beam and
corresponding derivatives ( ) zzjx ∂∂ :σ and ( ) zzjy ∂∂ :σ are shown in figure 2. The derivative
z
ijzd
∂
∂ :
can be derived from the dose distribution ( )zjzd : as
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as shown in figure 3 for a 290-MeV/u carbon beam. These precalculated values are used in the
dose optimization to shorten the time required to derive the robust dual-field plan.
4. Simulations
4.1 Treatment plan
To demonstrate the effectiveness of the proposed algorithm, we made treatment plans for three
target volumes located in an oval-shaped phantom (240 mm along the major axis and 200 mm along
the minor axis with 100-mm height) as shown in figure 4. The phantom is assumed to be
homogeneous and water equivalent. The voxel size was x=y=z=2.0 mm. We consider
different dual-field geometries for respective target volumes: a unidirectional geometry for target-1,
an opposing geometry for target-2 and an orthogonal geometry for target-3. For dose calculation
and dose delivery, we assumed a 290-MeV/u carbon beam. The maximum range of the scanned
carbon beam is 151.6 mm in water. The range of the beam is shifted using range shifter plates.
The effective field-size is set to be 150 mm square in the transverse directions. Spots are placed on
a regular, rectangular grid, with 4-mm spacing in both the beam- and the transversal-directions for
each field.
The optimizations were done with and without applying the proposed method for each of three
targets where the parameters maxPD ,
min
PD ,
o
PQ and uPQ were fixed to 2.0 Gy, 2.0 Gy, 1.0 and
1.0, respectively. In the following discussion, the former plan is referred to as a ‘robust plan’,
while the latter plan is referred to as a ‘conventional plan’. In the robust plan, we tentatively set the
penalty coefficients xQ , yQ and zQ to 50.0, 50.0 and 100.0, respectively. Qualitatively
speaking, these penalties should be defined to be proportional to the uncertainties in the respective
directions.
IMPT is strongly dependent on the choice of initial beam weights (starting conditions) used for
the optimization (Lomax 1999, Oelfke and Bortfeld 2000, Albertini et al 2007). We predetermine
the initial beam weights so as to deliver a flat spread-out Bragg peak (SOBP) type profile of 1 Gy
from each beam direction using the algorithm described in Krämer et al (2000).
4.2 Recalculation of the treatment plan
For the range and setup uncertainties analysis, the resultant six treatment plans, i.e., the robust and
the conventional plans for each of the three targets described in section 4.1, were recalculated with
combinational geometrical perturbations. The range was intentionally misplaced by varying the
phantom effective density by ±5%. Similarly, for setup uncertainties, the dose distribution of each
of two fields was calculated with intentional translations of ±5 mm in both the x- and y-directions.
Including the nominal range and position, 35 = 243 possible combinations of the total dose
distribution were derived for each plan.
5. Results and Discussion
5.1 Unidirectional geometry
Figure 5 shows treatment plans optimized for target-1 with a unidirectional-field geometry. The
upper row (figure 5(1)) shows the conventional plan, and the lower row (figure 5(2)) shows the
robust plan. Figures 5(1b) and 5(2b) are the resultant dose distributions when the nominal range
and setup position are realized for each field as assumed for the optimization. In both plans, the
planned dose distributions with a flatness of ±3% were realized in the target volume encompassed
with a yellow solid line. In the robust plan, a ‘safety margin’ is created at the distal, proximal and
lateral field edges by the method described in section 3.1. The dose contributions of the individual
beams are shown in figure 5(1a, 1c) and 5(2a, 2c). In the conventional plan, there are two distinct
regions of high dose gradient within the individual fields. Their locations correspond to the width
limits of the beam scanning. Owing to the predetermined initial beam weights, the dose within the
overlap region was kept flat at 1 Gy in each field. On the other hand, in the robust plan, a gradual
dose distribution was observed at the overlap region in each field, as shown in figures 5(2a) and (2c),
with evenly spaced isodose lines.
To show the effectiveness of our method for reducing the sensitivity of the treatment plans to
range and setup uncertainties in a unidirectional-field geometry, we recalculated 243 possible
combinations of perturbed dose distribution for each of the two plans. The maximum and
minimum dose distributions, defined as { }kiki DD ,2431:max Max−== and { }kiki DD ,2431:min Min−== (Lomax
2008), were derived for both plans, and shown in figures 6(1a, 2a) and 6(1b, 2b), respectively.
These two distributions can be considered to provide the positive and negative ‘error bars’ of
possible doses on either side of the nominal plans shown in figure 5(1b) and 5(2b). In the
conventional plan, hot doses up to 2.72 Gy and cold doses down to 1.28 Gy appeared around the
regions where distinct internal dose gradients were observed (see figures 5(1a) and 5(1c)). To show
the dose reduction clearly, we displayed the deviation between the minimum dose distribution and
the prescribed one within the target volume in figures 6(1c) and 6(2c) for the conventional and
robust plans, respectively. A significant dose reduction of 1.87 Gy was observed in the distal and
lateral field edges in the conventional plan, in addition to the cold doses caused by the steep dose
gradients at the field junctions, as shown in figure 6(1c). Over- and under-dosages were also
observed in the robust plan within the overlap region of the two fields (figures 6(2a) and 6(2b)).
However, because of the gradual dose distribution of each field, they were up to 2.28 Gy and down
to 1.72 Gy, respectively. Furthermore, the cold dose at the peripheral region of the target was
significantly reduced because of the expansion of the target region in step 1, as shown in figure
6(2c).
The dose volume histograms (DVHs) of 243 dose distributions are plotted in figure 7 for both
plans. Figure 7 also shows clearly the reduced sensitivity to range and setup uncertainties of the
robust plan compared to the conventional plan. The 95% doses (D95) were 86.0% (1.72 Gy) and
46.5% (0.93 Gy) for the robust and conventional plans, respectively, in the worst cases.
As described above, in the conventional plan, hot and cold doses were observed at the regions
where distinct in-field dose gradients exist. However, the predetermined initial Bragg peak weights
provide similar dose distributions to those of the multiple-patch technique used in the passive
irradiation method (Hug et al 2000) to smear the undesired hot and cold doses near the patch-field
junction. Hence, even the conventional plan described in this study provides rather a robust plan
compared to the normal field-patching technique.
5.2 Opposing geometry
Figure 8 shows treatment plans optimized for target-2 with an opposing-field geometry. The
upper and lower rows of the figure show the conventional and robust plans, respectively. Figures
8(1b) and 8(2b) are the resultant dose distributions when the nominal ranges and setup positions are
realized for each field as assumed for the optimization. The planned dose distributions were
realized in the target volume for both plans. In the robust plan, the high dose region was expanded
into the outer region of the target to ensure the target coverage for range and setup errors. The dose
contributions of the individual beams are shown in figures 8(1a, 1c) and 8(2a, 2c), respectively. In
this irradiation, the maximum penetration depths of the FTVs are 180 mm in water equivalent length
(mmWEL), which is slightly larger than the range of a 290-MeV/u carbon beam. In the
conventional plan, two distinct regions of high dose gradient were observed within the individual
fields, corresponding to the maximum ranges of the opposing beams. On the other hand, in the
robust plan, a gradual dose distribution was produced at the overlap region in each field, as shown in
figures 8(2a) and (2c) with evenly spaced isodose lines.
The maximum and minimum dose distributions were derived for the conventional and robust
plans for target-2 with an opposing-field geometry as shown in figures 9(1a, 2a) and 9(1b, 2b),
respectively. In the conventional plan, hot doses up to 2.56 Gy and cold doses down to 1.47 Gy
were observed in the regions where distinct high dose gradients exist (see figures 8(1a) and 8(1c)).
Furthermore, in the conventional plan, a dose reduction of 1.64 Gy was observed in the peripheral
region of the target, as shown in figure 9(1c), showing the deviations between the minimum dose
distribution and the prescribed one within the target volume. On the other hand, in the robust plan,
over- and under-dosages were observed only in the overlap region of the two fields, as shown in
figures 9(2a) and 9(2b). Owing to the gradual in-field dose distribution, the undesired hot and cold
doses observed in the conventional plan were smeared in the robust plan. The hot and cold doses
were up to 2.29 Gy and down to 1.71 Gy, respectively.
The DVHs of 243 dose distributions are plotted in figure 10 for the two plans. D95 in the worst
case was increased from 60.5% (1.21 Gy) to 83.8% (1.68 Gy) by applying the proposed robust
optimization method.
5.3 Orthogonal geometry
Figure 11 shows treatment plans optimized for target-3 with an orthogonal-field geometry. The
upper and lower rows of the figure show the conventional and robust plans, respectively. Figures
11(1b) and 11(2b) are the resultant nominal dose distributions showing good target coverage for both
plans. A ‘safety margin’ was created at the distal, proximal and lateral field edges in the robust
plan by the method described in section 3.1. The dose distributions of individual fields are
displayed in figures 11(1a, 1c) and 11(2a, 2c), respectively. In the robust plan, the dose profile in
the overlap region resembles the shape of a spiral staircase, making the dose gradient as shallow as
possible.
The maximum and minimum dose distributions were derived for the conventional and the robust
plan as shown in figures 12(1a, 2a) and 12(1b, 2b), respectively. The dose delivered to the lower
left part of the target in the axial image becomes relatively insensitive to range and setup variations,
especially in the robust plan. However, in both plans, hot and cold doses were possible at the inner
side of the field junction. In the conventional plan, a hot dose up to 2.81 Gy and a cold dose down
to 1.14 Gy were found around that region, while they are 2.66 Gy and 1.35 Gy in robust plan,
respectively. These findings are similar to those described in Unkelbach et al (2007), where the
probabilistic robust algorithm has been applied to optimize the dose distribution for the dual-field
geometry using an RTOG benchmark phantom. In the conventional plan, contrary to the robust
plan, a dose reduction of 1.80 Gy was also found in the peripheral region of the target, as shown in
figure 12(1c), illustrating the deviations between the minimum dose distribution and the prescribed
one within the target volume.
The DVHs of 243 dose distributions are plotted in figure 13 for the two plans. D95 in the worst
cases were 59.8% (1.21 Gy) for the conventional plan and 76.2% (1.68 Gy) for the robust plan.
5.4 Computation time
Optimization of the conventional dual-field plans took 7, 6 and 3 minutes (on a Dell Precision 690
workstation with 3.0 GB RAM) for the unidirectional, opposing and orthogonal geometries,
respectively. On the other hand, optimization of the robust plans took 24, 22 and 10 minutes for
these geometries. The total number of spots, spotsN , is 23290 (33936), 17816 (24624) and 9792
(15036) in the conventional (robust) plan, and the total number of voxels within the DTV, TN , is
115659 (161464), 77529 (121393) and 39709 (68335) for these geometries, respectively. The size
of the problem defined by TNNspots × in the robust plan is approximately twice that of the
problem in the conventional plan. Consequently, roughly speaking, the expansion of the target
volume (Step 1) prolongs the dose convolution time by a factor of two. Further prolongation of the
computation time was caused by the introduction of the gradient suppression terms in the objective
function (Step 2).
5.5 Outlook
For simplicity, we applied the proposed robust algorithm to the optimization of the physical dose
distribution in the dual-field geometry with a scanned carbon beam. However, this algorithm can
be applied to physical dose optimization in three or more fields geometry with any heavy
charged-particle beam including a proton beam. Our algorithm can also be applied to treatment
planning for a photon IMRT. To shorten the time required for the dose optimization, we prepared
filter tables of the lateral dose profile of the scanned pencil beam and its gradient preceding the dose
optimizations. In this study, the lateral dose profile of the scanned pencil beam was expressed as a
Gaussian function and its gradient was analytically derived. However, this method can also be used
for a non-Gaussian beam model in which the gradient cannot be derived analytically, by expressing
the gradient numerically.
A robust approach for IMPT/IMIT including the critical structures will be described in our next
paper. The assessment of the proposed method in a biological dose optimization scenario remains a
future study.
6. Conclusions
The quality of the dual-field strategy is quite sensitive to range and setup uncertainties. In this
paper, we described an algorithm to reduce the sensitivity of the dual-field plan to these
uncertainties in scanning irradiations. The algorithm is composed of two steps: 1) generating the
expanded target volume, and 2) solving the inverse problem where the terms suppressing the dose
gradient of individual fields are added into the objective function. The former step reduces the
undesired cold dose observed in the peripheral region of the target, while the latter step mitigates
the significant hot and cold doses generated at the field junctions. The effectiveness of the
algorithm was demonstrated for three extreme cases of dual fields with unidirectional, opposing
and orthogonal geometries. The proposed method greatly reduced the sensitivity of the dual-field
plan to range and setup errors. The 95% doses were increased to 86.0%, 83.8% and 76.2% from
46.5%, 60.5% and 59.8% for these geometries with the robust algorithm, respectively. Compared
to the conventional dual-field plan, we observed an increase of the optimization time for the
proposed robust plan by a factor of approximately three.
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Figure Captions
Figure 1. One-dimensional Gauss/differential Gauss filter used in treatment planning software. (a)
One-dimensional Gauss filter with standard deviations of 3 mm (solid-line), 4 mm (dashed-line) and
5 mm (dotted-line), respectively. (b) One-dimensional differential Gauss filter with standard
deviations of 3 mm (solid-line), 4 mm (dashed-line) and 5 mm (dotted-line), respectively.
Figure 2. (a) The lateral beam widths of a 290-MeV/u carbon beam in the x-direction (solid line),
xσ , and the y-direction (dotted line), yσ , as a function of depth z for range shifter thicknesses of
0 (black), 30 (red), 60 (green) and 90 (blue) mm water equivalent thickness, respectively. (b) The
corresponding derivatives of the lateral beam widths ( ) zzx ∂∂σ and ( ) zzy ∂∂σ .
Figure 3. (a) The planner-integrated doses of a 290-MeV/u carbon beam ( )zdz as a function of
depth z for range shifter thicknesses of 0 (black), 30 (red), 60 (green) and 90 (blue) mm water
equivalent thickness, respectively. (b) The corresponding derivatives of planner-integrated doses
with respect to z, ( ) zzdz ∂∂ .
Figure 4. Geometries of three target volumes (dark gray) located in the oval-shaped phantom (light
gray). The thick arrows indicate the beam directions delivered in each target.
Figure 5. The conventional treatment plan (upper row) and the robust treatment plan (lower row)
optimized for target-1 with a unidirectional-field geometry. The resultant dose distributions are
shown for the two plans with a color wash display in (1b) and (2b), where the yellow line outlines
the target. The dose distributions delivered by individual beams are displayed in (1a, c) and (2a, c)
with isodose lines, where the target volume is identified with dark yellow.
Figure 6. Maximum dose distributions (1a, 2a) and minimum dose distributions (1b, 2b) for the
conventional and robust plans, respectively. The yellow line outlines the target in (1a), (2a), (1b)
and (2b). The deviations between the minimum dose distribution and the prescribed one within the
target volume are shown in (1c) and (2c) for the two plans.
Figure 7. DVH of dose distributions recalculated for 243 different realizations of the beam ranges
and field positions for the conventional (black curves) and robust plans (red curves), respectively.
Figure 8. The conventional treatment plan (upper row) and the robust treatment plan (lower row)
optimized for target-2 with an opposing-field geometry. The resultant dose distributions are shown
for the two plans with a color wash display in (1b) and (2b), where the yellow line outlines the target.
The dose distributions delivered by individual beams are displayed in (1a, c) and (2a, c) with isodose
lines, where the target volume is identified with dark yellow.
Figure 9. Maximum dose distributions (1a, 2a) and minimum dose distributions (1b, 2b) for the
conventional and robust plans, respectively. The yellow line outlines the target in (1a), (2a), (1b)
and (2b). The deviations between the minimum dose distribution and the prescribed one within the
target volume are shown in (1c) and (2c) for the two plans.
Figure 10. DVH of dose distributions recalculated for 243 different realizations of the beam ranges
and field positions for the conventional (black curves) and robust plans (red curves), respectively.
Figure 11. The conventional treatment plan (upper row) and the robust treatment plan (lower row)
optimized for target-3 with an orthogonal-field geometry. The resultant dose distributions are
shown for the two plans with a color wash display in (1b) and (2b) where the yellow line outlines the
target. The dose distributions delivered by individual beams are displayed in (1a, c) and (2a, c)
with isodose lines, where the target volume is identified with dark yellow.
Figure 12. Maximum dose distributions (1a, 2a) and minimum dose distributions (1b, 2b) for the
conventional and robust plans, respectively. The yellow line outlines the target in (1a), (2a), (1b)
and (2b). The deviations between the minimum dose distribution and the prescribed one within the
target volume are shown in (1c) and (2c) for the two plans.
Figure 13. DVH of dose distributions recalculated for 243 different realizations of the beam ranges
and field positions for the conventional (black curves) and robust plans (red curves), respectively.
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